A detailed history of Planning Capital Management Corp transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Planning Capital Management Corp holds 3 shares of CPRX stock, worth $65. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Previous 1 200.0%
Holding current value
$65
Previous $16,000 275.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$15.19 - $21.35 $30 - $42
2 Added 200.0%
3 $60,000
Q2 2024

Aug 12, 2024

BUY
$14.68 - $16.92 $14 - $16
1 New
1 $16,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.25B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Planning Capital Management Corp Portfolio

Follow Planning Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Planning Capital Management Corp with notifications on news.